Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (141-150 of 350) with videos related to

Pageof 35
Sort By:
The Journal of Clinical Investigation|January 3, 2015
Proximity ligation assay evaluates IDH1R132H presentation in gliomasLukas Bunse, Theresa Schumacher, Felix Sahm, et al.
Neuro-Oncology|November 1, 2020
DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survivalJoost Dejaegher, Lien Solie, Zoé Hunin, et al.
Brain Pathology (Zurich, Switzerland)|August 15, 2013
BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumorsAvanita S Prabowo, Anand M Iyer, Tim J Veersema, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2013
Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytomaHemant K Bid, Aaron Kibler, Doris A Phelps, et al.
Acta Neuropathologica|May 9, 2019
Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomasKatharina Filipski, Yannick Braun, Jenny Zinke, et al.
Journal of Neurochemistry|July 1, 2014
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?Dieter Lemke, Markus Weiler, Jonas Blaes, et al.
Oncology Reports|October 18, 2017
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal diseaseMichael C Burger, Michael W Ronellenfitsch, Nadja I Lorenz, et al.
Journal of Neuro-Oncology|February 15, 2024
Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resectionDavid Wasilewski, Julia Onken, Paul Höricke, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2019
DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancerPhilipp Jurmeister, Anne Schöler, Alexander Arnold, et al.
Acta Neuropathologica|January 29, 2011
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytomaGenevieve Schindler, David Capper, Jochen Meyer, et al.
Pageof 35

Showing results (141-150 of 350) with videos related to

Sort By:
Pageof 35
The Journal of Clinical Investigation|January 3, 2015
Proximity ligation assay evaluates IDH1R132H presentation in gliomasLukas Bunse, Theresa Schumacher, Felix Sahm, et al.
Neuro-Oncology|November 1, 2020
DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survivalJoost Dejaegher, Lien Solie, Zoé Hunin, et al.
Brain Pathology (Zurich, Switzerland)|August 15, 2013
BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumorsAvanita S Prabowo, Anand M Iyer, Tim J Veersema, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2013
Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytomaHemant K Bid, Aaron Kibler, Doris A Phelps, et al.
Acta Neuropathologica|May 9, 2019
Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomasKatharina Filipski, Yannick Braun, Jenny Zinke, et al.
Journal of Neurochemistry|July 1, 2014
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?Dieter Lemke, Markus Weiler, Jonas Blaes, et al.
Oncology Reports|October 18, 2017
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal diseaseMichael C Burger, Michael W Ronellenfitsch, Nadja I Lorenz, et al.
Journal of Neuro-Oncology|February 15, 2024
Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resectionDavid Wasilewski, Julia Onken, Paul Höricke, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2019
DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancerPhilipp Jurmeister, Anne Schöler, Alexander Arnold, et al.
Acta Neuropathologica|January 29, 2011
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytomaGenevieve Schindler, David Capper, Jochen Meyer, et al.
Pageof 35